Cargando…
Do We Need Biomarkers for Disc Degeneration?
Disc degeneration plays a major role in this country’s medical, social and economic structure. The life-time prevalence of low back pain, which has disc degeneration as its cause, is about 80% in the general population. It is a primary cause of disability and estimated costs related to low back diso...
Autores principales: | Gruber, Helen E., Hanley, Edward N. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2716792/ https://www.ncbi.nlm.nih.gov/pubmed/19690643 |
Ejemplares similares
-
Observations on morphologic changes in the aging and degenerating human disc: Secondary collagen alterations
por: Gruber, Helen E, et al.
Publicado: (2002) -
Do we need a new levodopa?
por: Müller, Thomas
Publicado: (2016) -
Do We Need to Use Bats as Bioindicators?
por: Russo, Danilo, et al.
Publicado: (2021) -
Cervical disc degeneration and neck pain
por: Peng, Baogan, et al.
Publicado: (2018) -
A Novel Catechol-O-Methyltransferase Variant Associated with Human Disc Degeneration
por: Gruber, Helen E., et al.
Publicado: (2014)